BICO Group AB - Asset Resilience Ratio
BICO Group AB (BICO) has an Asset Resilience Ratio of 2.07% as of August 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check BICO PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2021)
This chart shows how BICO Group AB's Asset Resilience Ratio has changed over time. See BICO net asset quality score to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down BICO Group AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BICO stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr223.00 Million | 2.07% |
| Total Liquid Assets | Skr223.00 Million | 2.07% |
Asset Resilience Insights
- Limited Liquidity: BICO Group AB maintains only 2.07% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
BICO Group AB Industry Peers by Asset Resilience Ratio
Compare BICO Group AB's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
Annual Asset Resilience Ratio for BICO Group AB (2017–2021)
The table below shows the annual Asset Resilience Ratio data for BICO Group AB.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-08-31 | 10.19% | Skr993.80 Million ≈ $106.95 Million |
Skr9.75 Billion ≈ $1.05 Billion |
-1.16pp |
| 2020-08-31 | 11.34% | Skr187.11 Million ≈ $20.14 Million |
Skr1.65 Billion ≈ $177.50 Million |
-0.14pp |
| 2019-08-31 | 11.49% | Skr69.27 Million ≈ $7.45 Million |
Skr603.12 Million ≈ $64.91 Million |
-46.71pp |
| 2018-08-31 | 58.19% | Skr113.47 Million ≈ $12.21 Million |
Skr194.98 Million ≈ $20.98 Million |
+8.27pp |
| 2017-08-31 | 49.93% | Skr34.56 Million ≈ $3.72 Million |
Skr69.22 Million ≈ $7.45 Million |
-- |
About BICO Group AB
BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Life Science Solutions, and Lab Automation. The Bioprinting segment offers 3D bioprinters and bioinks with a range of technologies for various applications, resolutions, and volume/speed requirements, as well as… Read more